[Do new oral therapies show advantages in the basal therapy of multiple sclerosis? Con]

Nervenarzt. 2015 Apr;86(4):492-4. doi: 10.1007/s00115-014-4246-9.
[Article in German]
No abstract available

MeSH terms

  • Administration, Oral
  • Evidence-Based Medicine
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Multiple Sclerosis / diagnosis*
  • Multiple Sclerosis / drug therapy*
  • Treatment Outcome

Substances

  • Immunosuppressive Agents